Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Jim Wassil is recorded as COO at Vaxcyte, Inc. (PCVX). The proxy statement of Vaxcyte, Inc. reports total compensation of $5,809,971 for Jim Wassil in fiscal 2025, including a base salary of $600,000. Disclosed compensation is on record for 6 fiscal years. Jim Wassil has spoken on 6 earnings calls across 1 company, most recently for Vaxcyte, Inc. on February 24, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Start not stated–present
Recorded roles and call appearances connecting this person to public companies.
PCVX
COO
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Vaxcyte, Inc. (PCVX) | Executive Vice President and Chief Operating Officer | $600,000 | $5,809,971 |
| 2024 | Vaxcyte, Inc. (PCVX) | Executive Vice President and Chief Operating Officer | $550,000 | $17,867,617 |
| 2023 | Vaxcyte, Inc. (PCVX) | Executive Vice President and Chief Operating Officer | $508,000 | $5,401,215 |
| 2022 | Vaxcyte, Inc. (PCVX) | Executive Vice President and Chief Operating Officer | $485,685 | $6,991,203 |
| 2021 | Vaxcyte, Inc. (PCVX) | Executive Vice President and Chief Operating Officer | $451,800 | $1,970,336 |
| 2020 | Vaxcyte, Inc. (PCVX) | Executive Vice President and Chief Operating Officer | $369,643 | $1,357,549 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
